Theme: To Say There is Life after Cancer

Oncologists 2016
Past Report of Cancer Therapy 2015

Renowned Speakers

Oncologists 2016

Conferenceseries LLC invites all the participants from all over the world to attend “10th Global Annual Oncologists Meeting” during July11-13, 2016 at Cologne, Germany which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. Oncologists 2016 is the sequel of the past Oncology Conferences.

With members from around the world focused on learning about Oncologists; this is your best opportunity to reach the largest assemblage of participants from the Oncologists CommunityOncology SocietyEuropean Oncology ConferencesAmerican Oncology Society. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Oncology are hallmarks of this conference.

Conference Series LLC, the host of this conference is comprised of 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+Workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field is organizing conferences all over the globe.

To Say There is Life after Cancer, the theme of the upcoming Oncologists Meeting directs towards addressing main issues like Prevention, Diagnosis, and Treatment diseases of the Organ-related Cancers and its innovative techniques. Oncologists 2016 is one of the most appreciated Cancer Conferences organized by OMICS International. This Oncologists Meeting will have three days of discussions on methods and strategies related to management, quality improvement of Cancer as well as to explore the new ideas and concepts on global scale and the topics include lung cancer, breast cancer, bone cancer,  blood cancercervical cancercolon-rectum cancerprostate cancerthyroid cancer

The following are the scientific sessions has been designed for the upcoming Oncologists Meeting

Oncology

Oncology is a branch of medicine that deals with tumours. A medical professional who practices oncology is an oncologist. Integrative oncology manages the mind, body, and spirit. Modalities of movement, touch, nutrition, and mindfulness are used within conventional cancer care to address and improve symptoms and quality-of-life. That is why many practitioners, including medical doctors, have embraced the rapidly expanding field of integrative oncology, which fuses the best of conventional and alternative treatments. Immuno-oncology therapies activate our immune system, making it able to recognise cancer cells and destroy them. Since cancer cells are very different from normal cells in the body, the immune system attacks them when it is able to recognise them. Neuro-oncology evaluates and treats people with primary and secondary tumours of the brain, spinal cord, and the membranes surrounding the brain and spinal cord (meninges). Oncologic Emergencies, as the term implies, are complications resulting from a cancer itself, a paraneoplastic syndrome, or from treatment of cancer that require immediate attention and reversal, if possible. Inpatient treatment is a must, and often these conditions require intervention in an intensive care setting.

Related Oncology Conferences | Cancer Conferences | Oncologists Conferences

12th World Cancer Conference, September 26-28, 2016 London, UK;  Surgical Oncology Conference, October 03-05, 2016 Atlanta, Georgia, USA;  Leukemia Conference , October 17-18, 2016, Italy; 13th Asia-Pacific Oncologists Annual Meeting, October 17-19, 2016, Malaysia, 14th World Cancer Convention, November 21-23, 2016 Dubai, UAE, Bone Marrow Transplantation Conference, October 17-18, 2016,Italy; 18th International Psycho Oncology Society Congress, October 17-21, 2016, Ireland, ESMO World Congress on Gastrointestinal Cancer 2016 June 29-July 2, 2016, Spain; ESMO Symposium on Immuno-Oncology 2016, November 4-6, 2016, Switzerland; ESMO Asia 2016 Congress, December 16-19, 2016, Singapore;  European Lung Cancer Conference, May 5-8, 2017, Switzerland; ESMO 2017 Congress, September 8-12, 2017, Spain; World Cancer Congress, October 31-November  3, 2016, France; NCRI Cancer Conference, November  6-9, 2016, London, UK;12th Oncology Conferences Europe September 26-28, 2016 London, UK; 12th Cancer Science Events Europe September 26-28,2016 London, UK; Cancer Global Conferences Middle East November 21-23, 2016 Dubai, UAE, Oncology Conferences November 21-23, 2016 Dubai, UAE; Worldwide Cancer Events November 21-23, 2016 Dubai, UAE, Breast Cancer Conferences October 03-05, 2016 London, UK, Women’s Health Conferences October 03-05, 2016 London, UK.

Clinical Oncology

Clinical Oncology includes Medical Oncology (MO), Surgical Oncology (SO), Gynecologic OncologyHematologic Malignancies .Medical oncology communicates the results of clinical and experimental research in oncology and haematology, particularly with experimental therapeutics with the field of immunotherapy and chemotherapy. A surgical and non-surgical oncologist specializes in the removal of the tumours and surrounding tissue during an operation. A surgical also performs biopsies (the removal of a small amount of tissue for examination under a microscope). Hematologic malignancies are forms of cancer that begin in the cells of blood-forming tissue, such as the bone marrow, or in the cells of the immune system. Werner syndrome (WS), also known as "adult progeria is a rare, autosomal recessive progeroid syndrome (PS), which is characterized by the appearance of premature aging. Gynecologic oncology is a specialized field of medicine that focuses on cancers of the female reproductive system, including ovarian cancer, uterine cancer, vaginal cancer, cervical cancer, and vulvar cancer.

Related Oncology Conferences | Cancer Conferences | Oncologists Conferences

10th Global Annual Oncologists Meeting, July 11-13, 2016 Cologne, Germany; Melanoma Conference, July 14-15, 2016 Brisbane, Australia; Cervical Cancer Conference, August 04-05, 2016 Manchester, UK; Oral Cancer Conference, August 15-17, 2016 Portland, Oregon, USA; 2nd Prostate Cancer Conference, August 22-23, 2016 Philadelphia, USA, Throat Cancer Conference August 15-17, 2016 Portland, Oregon, USA, Carcinoma Conference, July 14-15, 2016 Brisbane, Australia, Mouth Cancer Conference August 15-17, 2016 Portland, Oregon, USA, The Japanese Society of Medical Oncology Annual Meeting, July 28-30, 2016, Japan; 48th Congress of the International Society of Pediatric Oncology, October 19-22, 2016, Ireland, 8th European Multidisciplinary Meeting on Urological Cancers, November 24-27, 2016, Italy; European Lung Cancer Conference, May 5-8, 2017, Switzerland; Multidisciplinary Management of Lung Cancer, June 26-28, 2016, Russia; Multidisciplinary Management of Head and Neck Oncology, June 26-29, 2016, Italy,12th Oncology Conferences Europe September 26-28, 2016 London, UK, 12th Cancer Science Events Europe September 26-28, 2016 London, UK, Cancer Global Conferences Middle East November 21-23, 2016 Dubai, UAE, Worldwide Cancer Events November 21-23, 2016 Dubai, UAE, Breast Cancer Conferences October 03-05, 2016 London, UK, Women’s Health Conferences October 03-05, 2016 London, UK.

Pediatric Oncology

Pediatric oncologists are the physicians who have specialized in pediatrics and then received further training in medical oncology and hematology. This means that rather than using surgery or radiation therapy to treat cancer, pediatric oncologists typically use medications and chemotherapy. Myeloid leukemia is a type of leukemia affecting myeloid tissue. In medicine, histiocytosis refers to an excessive number of histiocytes, (tissue macrophages), and is typically used to refer to a group of rare diseases which share this as a characteristic. Occasionally and confusingly, the term "histiocytosis" is sometimes used to refer to individual diseases. Acute lymphoblastic leukemia, also known as acute lymphocytic leukemia or acute lymphoid leukemia (ALL) is an acute form of leukaemia, or cancer of the white blood cells, characterized by the overproduction and accumulation of cancerous, immature white blood cells, known as lymphoblasts. A brain tumour or intracranial neoplasm occurs when abnormal cells form within the brain. There are two main types of tumours: malignant tumours and benign tumours.

Related Oncology Conferences | Cancer Conferences | Oncologists Conferences

2nd  Paediatric Oncology Conference , June 22-23, 2017 Philadelphia, USA; 2nd  Prostate Cancer Conference, August 22-23, 2016 Philadelphia, Pennsylvania, USA; 10th Global Annual Oncologists Meeting, July 11-13, 2016 Cologne, Germany; Melanoma Conference, July 14-15, 2016 Brisbane, Australia;12th World Cancer ConferenceSeptember 26-28, 2016 London, UK , Carcinoma Conference, July 14-15, 2016 Brisbane, Australia, 48th Congress of the International Society of Paediatric Oncology, October 19-22, 2016, Ireland; 17th International Symposium on Paediatric Neuro-Oncology (ISPNO), June 12-15, 2016  Liverpool, United Kingdom; International Society of Paediatric Oncology (SIOP) 2017 Congress, October 12-15, 2017 Washington, USA; 6th ESO-SIOPE Master class in Paediatric Oncology, June 11-16, 2016 Berlin, Germany; 13th Congress of the European Society of Paediatric Otorhinolaryngology, June 18-21, 2016 Lisboa, Portugal; Paediatric Neuro-Oncology, Feb 13 2017 London, United Kingdom; International Society of Paediatric Surgical Oncology (IPSO) Symposium 2016, May 14-15, 2016 San Diego, California; Paediatric Academic Society Conference, May 6–9, 2017, California, USA, 12th Oncology Conferences Europe September 26-28, 2016 London, UK, 12th Cancer Science Events Europe September 26-28, 2016 London, UK, Cancer Global Conferences Middle East November 21-23, 2016 Dubai, UAE, Oncology Conferences November 21-23, 2016 Dubai, UAE, Worldwide Cancer Events November 21-23, 2016 Dubai, UAE, Breast Cancer Conferences October 03-05, 2016 London, UK, Women’s Health ConferenceOctober 03-05, 2016 London, UK

Radiation oncology

Radiation oncology is one of the three primary specialties, the other two being surgical and medical oncology, involved in the treatment of cancer. A Radiation Oncologist is a specialist physician who uses ionizing radiation (such as megavoltage X-rays or radionuclides) in the treatment of cancer. Brachytherapy is an advanced cancer treatment. Radioactive seeds or sources are placed in or near the tumour itself, giving a high radiation dose to the tumour while reducing the radiation exposure in the surrounding healthy tissues. External beam therapy (EBT), also called external radiation therapy, is a method for delivering a beam or several beams of high-energy x-rays to a patient's tumour. Intraoperative radiation therapy, or IORT is the application of therapeutic levels of radiation to the tumour bed while the area is exposed during surgery. Systemic radiation therapy is a type of radiation therapy in which radioactive material travels through the bloodstream to reach cells all over the body. Systemic radiation is used to treat certain types of cancer, such as thyroid cancer, or to relieve pain when cancer has spread (metastasized) to the bone. Radio immunotherapy (RIT) uses an antibody labelled with a radionuclide to deliver cytotoxic radiation to a target cell. In cancer therapy, an antibody with specificity for a tumour-associated antigen is used to deliver a lethal dose of radiation to the tumour cells.

Related Oncology Conferences | Cancer Conferences | Oncologists Conferences

Nuclear Medicine Conference, July14-15, 2016, Cologne, Germany; 5th  Radiology & Imaging Conference, September 19-20, 2016,Las Vegas, USA; Medical Imaging Conference, October 20-21, 2016, Chicago, USA;  Radiation Oncology Conference, November 21-22, 2016, Dubai, UAE, Radiation Therapy Conference, July14-15, 2016, Cologne, Germany,  Medical Devices Conference, March 27-29, 2017, Orlando, USA; American Society for Radiation Oncology Annual Meeting, September 25-28, 2016, Boston, USA; UK Radiation Oncology Conference, June 06-07, 2016, UK;  58th Annual Meeting of American Society of Therapeutic Radiology & Oncology, September 25-28, 2016, USA;  2nd World Congress on Controversies in Breast Cancer, September 08-11, 2016, Barcelona, Spain; 29th Annual Congress of European Association of Nuclear Medicine, Oct 15-19, 2016, Spain; UICC World Cancer Congress, October 31- November 03, 2016, France; 17th World Conference on Lung Cancer, December 04-07, 2016, Austria; ASRT Radiation Therapy Conference, September 25-27, 2016, USA,12th Oncology Conferences Europe September 26-28, 2016 London, UK, 12th Cancer Science Events Europe September 26-28, 2016 London, UK, Cancer Global Conferences Middle East November 21-23, 2016 Dubai, UAE, Oncology Conferences November 21-23, 2016 Dubai, UAE, Worldwide Cancer Events November 21-23, 2016 Dubai, UAE, Breast Cancer Conferences October 03-05, 2016 London, UK, Women’s Health Conferences October 03-05, 2016 London, UK

Hematologic Oncology

Hematologic oncology: The diagnosis, treatment and prevention of blood diseases (hematology) and cancer (oncology) and research into them. Hematologic oncology includes such diseases as iron deficiency anemia, hemophilia, sickle cell disease, the thalassemia’s, leukaemia and lymphomas, as well as cancers of other organs. Tumours of the hematopoietic and lymphoid tissues or haematopoietic and lymphoid malignancies are tumours that affect the blood, bone marrow, lymph, and lymphatic system. Plasma cell dyscrasias are disorders of the plasma cells. Plasma cell dyscrasias are produced as a result of abnormal proliferation of a monoclonal population of plasma cells that may or may not secrete detectable levels of a monoclonal immunoglobulin or immunoglobulin fragment (paraprotein or M protein). Chronic lymphocytic leukemia (CLL) is a type of cancer of the blood and bone marrow - the spongy tissue inside bones where blood cells are made. Myelodysplastic or myeloproliferative neoplasms are a group of diseases in which the bone marrow makes too many white blood cells. Both Hodgkin's lymphoma and non-Hodgkin's lymphomaare lymphomas, a type of cancer that begins in a subset of white blood cells called lymphocytes.

Related Oncology Conferences | Cancer Conferences | Oncologists Conferences

6th Hematology Conference, October 03-05, 2016 Florida, USA; 5th World Hematologists CongressAugust 18-19, 2016, London, UK; 7th Blood Cancer ConferenceMay 25-27, 2017 London, UK; 5th European Immunology ConferenceJuly 21-23, 2016  Berlin, Germany;  Leukemia ConferenceOctober17-18, 2016, Rome, Italy; 29th ASPHO Annual Meeting, May 11-14, 2016 Minneapolis, USA; Bone Marrow Transplantation Conference, October 17-18, 2016, 15th International Paediatric Haematology & Oncology Update Meeting (IPHOUM)May 12–15, 2016  Edinburgh, UK; 4th International Conference on Advances in Hematology and Oncology (ICAHO) 2016August 13-14, 2016 Idaho, USA ;26th Annual Mayo Clinic Hematology/Oncology Reviews 2016, July 27-30, 2016 Florida , USA; Comprehensive Hematology & Oncology ReviewSeptember 24-27, 2016 Washington, USA; Debates and Didactics in Hematology and OncologyJuly 27-31, 2016 Georgia, USA; ANZCHOG Meeting 2016June 18-20, 2016 Cairns City, Australia; 7th JSH International Symposium for Hematological malignanciesMay 13-14, 2016 Awaji, Japan; 58th ASH Annual Meeting & ExpositionDec 2016 California, USA,12th Oncology Conferences Europe September 26-28, 2016 London, UK, 12th Cancer Science Events Europe September 26-28, 2016 London, UK, Cancer Global Conferences Middle East November 21-23, 2016 Dubai, UAE, Oncology Conferences November 21-23, 2016 Dubai, UAE, Worldwide Cancer Events November 21-23, 2016 Dubai, UAE, Breast Cancer Conferences October 03-05, 2016 London, UK, Women’s Health Conferences October 03-05, 2016 London, UK.

Chemotherapy

Chemotherapeutic agent an agent used to treat cancer administered in regimens of one or more cycles, combining two or more agents over a period of days to weeks. Intravenous chemotherapy is one way to receive cancer-fighting medicine. Oral chemotherapy (chemo) is a treatment used to shrink a tumour or kill cancer cells. Oral chemo is usually taken in the form of a pill or capsule. Arterial chemotherapy infusion of the liver and chemoembolization of the liver (transarterial chemoembolization or TACE) are similar procedures that are used for the treatment of cancers in the liver. Adjuvant therapy or care, also called adjunct therapy or adjunctive therapy or care, is therapy that is given in addition to the primary, main, or initial therapy to maximize its effectiveness. Topical chemotherapy is a cream or lotion applied directly to the skin cancer. Different drugs cause different side effects. Certain types of chemotherapy often have specific side effects. But, each person’s experience is different.

Related Oncology Conferences | Cancer Conferences | Oncologists Conferences

2nd Antimicrobial Agents Conference, June 06-07, 2016, Dallas, USA; 14th World  Cancer Therapy CongressDecember 08-10, 2016, Dallas, USA; 10th Global Annual Oncologists MeetingJuly11-13, 2016, Cologne, Germany;  Cervical Cancer ConferenceAugust 04-05, 2016, Manchester, UK; 7th Blood Cancer ConferenceMay 25-27, 2017, London, UK;  Chemotherapy Conference, June 06-07, 2016, Dallas, USA, International Society of Chemotherapy for Infection and Cancer Annual MeetingNovember 24-27, 2017, Taipei;  British Society for Antimicrobial Chemotherapy Annual Meeting,  June 21-22, 2016, UK; 58th Annual Meeting of American Society of Therapeutic Radiology & Oncology, September 25-28, 2016, USASydney Cancer Conference, September 22-23, 2016, Australia; 7th Asia Pacific Lung Cancer Conference, May 13-16, 2016, USA; ESGO Gynaecology Oncology Conference, September 08-11, 2016, Turkey; 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for TomorrowNovember 9-11, 2016, New York;  Commissioning Chemotherapy Conference,  November 29, 2016, UK,12th Oncology Conferences Europe September 26-28, 2016 London, UK, 12th Cancer Science Events Europe September 26-28, 2016 London, UK, Cancer Global Conferences Middle East November 21-23, 2016 Dubai, UAE, Oncology Conferences November 21-23, 2016 Dubai, UAE, Worldwide Cancer Events November 21-23, 2016 Dubai, UAE, Breast Cancer Conferences October 03-05, 2016 London, UK, Women’s Health Conferences October 03-05, 2016 London, UK

Oncologists

Oncologists are doctors who specialize in treating people with cancer. They are responsible for the care of a patient from the moment of a cancer diagnosis throughout the course of the disease. A medical oncologist specializes in treating cancer with chemotherapy such as targeted therapy and oral (in pill form) chemotherapy. A surgical oncologist specializes in the removal of the tumour and surrounding tissue during an operation. And a radiation oncologist specializes in treating cancer with radiation therapy (the use of high-energy x-rays or other particles to kill cancer cells).

Related Oncology Conferences | Cancer Conferences | Oncologists Conferences

Cancer Diagnostics Conference  June 13-15, 2016 Rome, Italy, 2nd Prostate Cancer Conference, August 22-23, 2016 Philadelphia, Pennsylvania, USA, 12th World Cancer Conference, September 26-28, 2016 London, UK, 13th Asia-Pacific Oncologists Annual Meeting, October 17-19, 2016 Kuala Lumpur, Malaysia, 16th Global Annual Oncologists Meeting, April 19-21, 2017 Zurich, Switzerland, ESMO Academy 2016, 26 Aug - 28 Aug 2016, Oxford, United Kingdom, ESMO Symposium on Immuno-Oncology 2016, 04 Nov - 06 Nov 2016,  Lausanne, Switzerland, 8th European Multidisciplinary Meeting on Urological Cancers, 24 Nov - 27 Nov 2016, Milan, Italy, ESMO Asia 2016 Congress, 16 Dec - 19 Dec 2016, Singapore, 48th Annual Congress of the International Society of Paediatric Oncology, 19 Oct - 22 Oct 2016, Dublin, Ireland, World Cancer Congress 2016, 31 Oct - 03 Nov 2016, Paris, France, The Annual Meeting: Future of Patient-Centered Care and Research, June 3-7, 2016, McCormick Place, Chicago, 2016 Annual Scientific Meeting,(COSA 2016) 15 - 17 November 2016, Queensland, Australia, 12th Oncology Conferences Europe September 26-28, 2016 London, UK, 12th Cancer Science Events Europe September 26-28, 2016 London, UK, Cancer Global Conferences Middle East November 21-23, 2016 Dubai, UAE, Oncology Conferences November 21-23, 2016 Dubai, UAE, Worldwide Cancer Events November 21-23, 2016 Dubai, UAE, Breast Cancer Conferences October 03-05, 2016 London, UK, Women’s Health Conferences October 03-05, 2016 London, UK

Organ Specific Cancer

Brain and spinal cord tumours may be either benign (not cancer) or malignant (cancer).Both benign and malignant tumours cause signs and symptoms and need treatment. Benign brain and spinal cord tumours grow and press on nearby areas of the brain but rarely spread into other parts of the brain. Malignant brain and spinal cord tumours are likely to grow quickly and spread into other parts of the brain. The bones around the nasal cavity have small hollow spaces in them called paranasal sinuses. These sinuses affect the sound and tone of voice. The exact causes of nasal and sinus cancers are not known. Cancers that are known collectively as head and neck cancers usually begin in the squamous cells that line the moist, mucosal surfaces inside the head and neck (for example, inside the mouth, the nose, and the throat). The most dangerous form of skin cancer is these cancerous growths develop once unrepaired DNA damage to skin cells most frequently caused by ultraviolet radiation from sunshine or tanning beds triggers mutations genetic defects that lead the skin cells to multiply rapidly and form malignant tumors. Breast cancer is cancer that develops from breast tissue. Signs of breast cancer may include a lump in the breast, a change in breast shape, dimpling of the skin, fluid coming from the nipple, or a red scaly patch of skin. Cervical cancer is a cancer arising from the cervix. It is due to the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Pulmonary metastases of renal cell carcinoma (RCC) are associated with poor prognosis. Inhalation therapy with interleukin-2 (IL-2) is thus an appealing method for palliation. Carcinoma of the thyroid gland is an uncommon cancer but is the most common malignancy of the endocrine system. Differentiated tumours (papillary or follicular) are highly treatable and usually curable. Hepatocellular carcinoma (HCC, also called malignant hepatoma) is the most common type of liver cancer. Most cases of HCC are secondary to either a viral hepatitis infection (hepatitis B or C) or cirrhosis (alcoholism being the most common cause of liver cirrhosis). Reproductive cancers start in the organs related to reproduction. These organs are located in the pelvis. The pelvis is the area in the lower belly between the hip bones.

Related Oncology Conferences | Cancer Conferences | Oncologists Conferences

Pancreatic Conference, September 26-27, 2016 Toronto, Ontario, Canada, 14th World Cancer Convention, November 21-23, 2016 Dubai, UAE, 14th World  Cancer Therapy Congress, December 05-07, 2016 Philadelphia, Pennsylvania, USA, Neuroendocrine Cancer and Radiation Medicine Conference, Nov 7-9, 2016 Las Vegas, USA, Colorectal Cancer Conference September 26-27, 2016 Toronto, Ontario Canada, Bone Marrow Transplantation Conference October17-18, 2016, Rome, Italy ,16th Biennial Meeting of the International Gynecologic Cancer Society, October 29 – 31​, 2016 Lisbon, Portugal, Engineering and Physical Sciences in Oncology, June 25-28, 2016, Boston, Massachusetts, International Conference on Innovation and Biomarkers in Cancer Drug Development, September 8 - 9, 2016, Brussels, Belgium, EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium, November 29 – December 2, 2016, Munich, Germany, Molecular Biology in Clinical Oncology Workshop, July 24-31, 2016, Colorado, USA,  Fifth JCA-AACR Special Joint Conference on the Latest Advances in Hematological Cancer Research: From Basic Science to Therapeutics, July 13-15, 2016, Urayasu, Japan, ECCO-AACR-EORTC-ESMO Workshop on Methods in Clinical Cancer Research, June 18-24, 2016, Zeist, The Netherlands, Women’s Health Conferences October 03-05, 2016 London, UK, 12th Oncology Conferences Europe September 26-28, 2016 London, UK, 12th Cancer Science Events Europe September 26-28, 2016 London, UK, Oncology Conferences November 21-23, 2016 Dubai, UAE, Cancer Global Conferences Middle East November 21-23, 2016 Dubai, UAE,  Worldwide Cancer Events November 21-23, 2016 Dubai, UAE, Breast Cancer Conferences October 03-05, 2016 London, UK, 

Cancer: Causes

Metastasis, or metastatic disease, is the spread of a cancer or other disease from one organ or part to another not directly connected with it. An oncovirus is a virus that can cause cancer. This term originated from studies of acutely transforming retroviruses in the 1950–60s, often called on coronaviruses to denote their RNA virus origin. Carcinogenesis or oncogenesis or tumorigenesis is the actual formation of a cancer, whereby normal cells are transformed into cancer cells . Mutagenesis is a process by which the genetic information of an organism is changed in a stable manner, resulting in a mutation. It may occur spontaneously in nature or as a result of exposure to mutagens. Apoptosis is a form of physiological cell death mediated by caspases, a unique family of intracellular cysteine proteases.

Related Oncology Conferences | Cancer Conferences | Oncologists Conferences

Cancer Diagnostics Conference & Expo, June 13-15, 2016 Rome, Italy, 2nd International Conference on Prostate Cancer and Therapeutics, August 22-23, 2016 Philadelphia, Pennsylvania, USA 12th World Cancer Conference, September 26-28, 2016 London, UK, 13th Asia-Pacific Oncologists Annual Meeting, October 17-19, 2016 Kuala Lumpur, Malaysia, 16th Global Annual Oncologists Meeting, April 19-21, 2017 Zurich, Switzerland, ESMO Academy 2016, 26 Aug - 28 Aug 2016, Oxford, United Kingdom, ESMO Symposium on Immuno-Oncology 2016, 04 Nov - 06 Nov 2016,  Lausanne, Switzerland, 8th European Multidisciplinary Meeting on Urological Cancers, 24 Nov - 27 Nov 2016, Milan, Italy, ESMO Asia 2016 Congress, 16 Dec - 19 Dec 2016, Singapore, 48th Annual Congress of the International Society of Paediatric Oncology, 19 Oct - 22 Oct 2016, Dublin, Ireland, World Cancer Congress 2016, 31 Oct - 03 Nov 2016, Paris, France, The Annual Meeting: Future of Patient-Centered Care and Research, June 3-7, 2016, McCormick Place, Chicago, 2016 Annual Scientific Meeting,(COSA 2016) 15 - 17 November 2016, Queensland, Australia. 

Cancer: Diagnostics and Staging

X-radiation (composed of X-rays) is a form of electromagnetic radiation Magnetic resonance imaging (MRI) is a type of scan that uses strong magnetic fields and radio waves to produce detailed images of the inside of the body. An ultrasound scan, sometimes called a sonogram, is a procedure that uses high-frequency sound waves to create an image of part of the inside of the body. A biopsy is a medical test commonly performed by a surgeon, interventional radiologist, or an interventional cardiologist involving sampling of cells or tissues for examination. A complete blood count (CBC) gives important information about the kinds and numbers of cells in the blood, especially red blood cells camera.gif, white blood cells camera.gif, and platelets. Cancer staging is the process of determining the extent to which a cancer has developed by spreading. The TNM Classification of Malignant Tumours (TNM) is a cancer staging notation system that gives codes to describe the stage of a person's cancer, when this originates with a solid tumour. Pathologic staging, where a pathologist examines sections of tissue, can be particularly problematic for two specific reasons: visual discretion and random sampling of tissue.

Related Oncology Conferences | Cancer Conferences | Oncologists Conferences

Surgical Oncology Conference, October 03-05, 2016 Atlanta, Georgia, USA; 3th Asia-Pacific Oncologists Annual Meeting, October 17-19, 2016 Kuala Lumpur, Malaysia;  Radiation Oncology Conference, November 21-22, 2016 Dubai, UAE; 14th World  Cancer Therapy Congress, December 05-07, 2016 Philadelphia, Pennsylvania, USA; 48th Annual Congress of the International Society of Paediatric Oncology, October 19-22, 2016 Dublin, Ireland; ASCO Annual Meeting, June 3-7, 2016 Chicago, Illionois; 16th Biennial Meeting of the International Gynecologic Cancer Society, October 29-31​ Lisbon, Portugal; 22nd Annual Meeting of the German Society for Radiooncology, June  16-19 Berlin, Germany; 8th Annual UAE Cancer Congress, October 22-23, 2016 Dubai, UAE; Breast Cancer Research Symposium, July 22-23, 2016 London, UK; International Cancer Education Conference, September 14-16, 2016 Bethesda, USA; World Cancer Congress , October 31 - November 3 Paris, France; NCRI Cancer Conference, November 6-9, 2016 Liverpool, UK,12th Oncology Conferences Europe September 26-28, 2016 London, UK, 12th Cancer Science Events Europe September 26-28, 2016 London, UK, Cancer Global Conferences Middle East November 21-23, 2016 Dubai, UAE, Oncology Conferences November 21-23, 2016 Dubai, UAE, Worldwide Cancer Events November 21-23, 2016 Dubai, UAE, Breast Cancer Conferences October 03-05, 2016 London, UK, Women’s Health Conferences October 03-05, 2016 London, UK

Cancer: Treatment and Therapy

Various therapeutics are now available to treat cancer.. Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Gene therapy is the therapeutic delivery of nucleic acid polymers into a patient's cells as a drug to treat disease. Gene therapy could be a way to fix a genetic problem at its source. A bone marrow transplant is a procedure to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Immunotherapy is a new class of cancer treatment that works to harness the innate powers of the immune system to fight cancer. Angiogenesis is the formation of new blood vessels. This process involves the migration, growth, and differentiation of endothelial cells, which line the inside wall of blood vessels. Hyperthermia is elevated body temperature due to failed thermoregulation that occurs when a body produces or absorbs more heat than it dissipates.

Related Oncology Conferences | Cancer Conferences | Oncologists Conferences

Pancreatic Conference, September 26-27, 2016 Toronto, Ontario, Canada,, 14th World Cancer Convention, November 21-23, 2016 Dubai, UAE, 14th World Congress on Cancer Therapy, December 05-07, 2016 Philadelphia, Pennsylvania, USA, International conference on Neuroendocrine Cancer and Radiation Medicine, Nov 7-9, 2016 Las Vegas, USA, Colorecteal Conference , September 26-27, 2016 Toronto, Ontario, Canada,16th Biennial Meeting of the International Gynecologic Cancer Society, October 29 – 31​, 2016 Lisbon, Portugal, Engineering and Physical Sciences in Oncology, June 25-28, 2016, Boston, Massachusetts, International Conference on Innovation and Biomarkers in Cancer Drug Development, September 8 - 9, 2016, Brussels, Belgium, EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium, November 29 – December 2, 2016, Munich, Germany, Molecular Biology in Clinical Oncology Workshop, July 24-31, 2016, Colorado, USA,  Fifth JCA-AACR Special Joint Conference on the Latest Advances in Hematological Cancer Research: From Basic Science to Therapeutics, July 13-15, 2016, Urayasu, Japan, ECCO-AACR-EORTC-ESMO Workshop on Methods in Clinical Cancer Research, June 18-24, 2016, Zeist, The Netherlands.

Cancer Biomarkers

Protein Biomarkers can be used as biomarkers for early detection of cancers especially used for the identification of breast cancer. Diagnostic Patients with suspected pancreatic cancer will undergo an initial CT scan to determine if a suspect mass is localized and removed by surgery 63% of patients will be diagnosed with non-resectable stage III and IV disease and a biopsy will be undertaken to confirm pancreatic cancer by H&E pathological analysis.  The presence of cancerous cells via pathology is very challenging due to high numbers of non-cancerous stromal infiltrating cells and administration of chemotherapy or enrolment into a clinical trial will only commence on definitive diagnosis of pancreatic cancer. These will notice specifically stains neoplastic pancreatic cells would enable the pathologist to confidently diagnose pancreatic cancer and thus offer appropriate cancer treatment to the patients. The Novel Biomarker BI-010 has been identified as a highly sensitive (98%) and specific (95%) IHC marker for pancreatic cancer and CRT is seeking a partner to develop an IHC based test to detect BI-010 in fine needle aspirate biopsies from biopsy samples.

Related Oncology Conferences | Cancer Conferences | Oncologists Conferences

Gynecologic Oncology Conference, May 19-21, 2016 San Antonio, Texas, USA ; Cancer Diagnostics Conference June 13-15, 2016 Rome, Italy; 7th Molecular Cancer Conference, September 15-16, 2016 Berlin, Germany; 12th World Cancer Conference, September 26-28, 2016 London, UK; Cancer Biomarkers Conference September 15-16, 2016 Berlin, Germany, 8th  Biomarkers & Clinical Research Conference, December 05-07, 2016 Philadelphia, USA; 12th Annual Biomarkers & Diagnostics World Congress, May 16-19 Philadelphia, USA; 43rd International Society of Oncology and Biomarkers, September 1-6, 2016 Chicago, USA; International Summit on Biomarkers and Therapeutic Advances in Radiation Oncology, June 20-22, 2016 Montreal, Canada; 6th Munich Biomarker Conference, November 29-30, 2016 Munchen, Germany; 18th International Conference on Biomarkers and Clinical Medicine, May 16-17,2016 Paris, France; 4th Annual Immuno-Oncology Summit, August 29-September 2, 2016 Boston, USA; 2nd Biomarkers, Diagnostics & Clinical Research Conference, September 19-20 Boston, USA; Biomarkers and Targeted Therapeutics in Sjögren’s (BATTS) Conference, September 19-22, 2016 Oklahoma, USA, EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium, November 29 – December 2, 2016, Munich, Germany, Molecular Biology in Clinical Oncology Workshop, July 24-31, 2016, Colorado, USA,  Fifth JCA-AACR Special Joint Conference on the Latest Advances in Hematological Cancer Research: From Basic Science to Therapeutics, July 13-15, 2016, Urayasu, Japan, ECCO-AACR-EORTC-ESMO Workshop on Methods in Clinical Cancer Research, June 18-24, 2016, Zeist, The Netherlands.

Cancer and Pharmacology

Treatment often fails when cancer becomes resistant to anti-cancer drugs. Thus, drug resistance is a big challenge facing the survival of cancer patients. Research in discovering and designing drugs with new chemistry structure or mechanism of action is critical to overcome the drug resistance problem and give patient better chance to survive longer. Monoclonal antibody therapy is a form of immunotherapy that uses monoclonal antibodies (mAb) to specifically bind to specific cells or proteins. Nanomedicine is the application of nanotechnology which made its debut with greatly increased possibilities in the field of medicine. Nano medicine desires to deliver research tools and clinically reformative devices in the near future.The clinical toxicology importance of any drug interaction depends on factors that are drug-patient and administration related. Generally, a doubling or more in plasma drug concentration has the potential for enhanced adverse or beneficial drug response Drug interactions in oncology are of particular importance owing to the narrow therapeutic index and the inherent toxicity of anticancer agents. Interactions with other medications can causes small changes  pharmacokinetics or pharmacodynamics of a chemotherapy agent that could significantly alter its efficacy or toxicity.

Related Oncology Conferences | Cancer Conferences | Oncologists Conferences

6th Asia-Pacific Pharma Congress, July 11-13, 2016 Kuala Lumpur, Malaysia; International Pharmacy Conference, July 14-15, 2016 Philadelphia, Pennsylvania, USA; 9th World Drug Delivery Summit, June 30-July 02, 2016 New Orleans, Louisiana, USA; 2nd Bio pharmaceutics Conference, September 14-16, 2016 San Antonio, Texas, USA; 3rd World  Pharmacology Congress, August 08-10, 2016 Birmingham, UK; Biologic Drugs Conference, September 14-16, 2016 San Antonio, Texas, USA, 10th Drug Design & Medicinal Chemistry Conference, 11-12 May 2016, Berlin, Germany;  3rd 3D Models & Drug Screening Conference, 11- 12 May 2016, Berlin, Germany; Sixth European Workshop in Drug Synthesis 15- 19 May 2016, Siena, Italy 2nd Annual Formulation & Drug Delivery Congress 2016, 18-19 May 2016, London UK ; Vaccine Technology VI ,12-17 Jun 2016, Albufeira, Portugal London, United Kingdom, 12th Oncology Conferences Europe September 26-28, 2016 London, UK, ,  Fifth JCA-AACR Special Joint Conference on the Latest Advances in Hematological Cancer Research: From Basic Science to Therapeutics, July 13-15, 2016, Urayasu, Japan, ECCO-AACR-EORTC-ESMO Workshop on Methods in Clinical Cancer Research, June 18-24, 2016, Zeist, The Netherlands, ,  Fifth JCA-AACR Special Joint Conference on the Latest Advances in Hematological Cancer Research: From Basic Science to Therapeutics, July 13-15, 2016, Urayasu, Japan, ECCO-AACR-EORTC-ESMO Workshop on Methods in Clinical Cancer Research, June 18-24, 2016, Zeist, The Netherlands.

Cancer: Vaccines and Prevention

Cancer Vaccines  help the body’s immune system prepare for future attacks. Vaccines consist of killed or modified microbes, parts of microbial DNA that trick the body into thinking an infection has occurred. A prophylactic vaccination is a selective exposure to a weakened or diluted form of an infectious agent to encourage a patient to form antibodies. Vaccination given during childhood is generally safe. Adverse effects if any are generally mild. The rate of side effects depends on the vaccine in question. Some common side effects include: fever, pain around the injection site, and muscle aches. Additionally, some individuals may be allergic to ingredients in the vaccine. MMR vaccine is rarely associated with febrile seizures.Cancer Prevention  or   chemoprevention is defined as the use of natural, synthetic, or biologic chemical agents to reverse, suppress, or prevent carcinogenic progression to invasive cancer. Screening, in medicine, is a strategy used in a population to identify the possible presence of an as-yet-undiagnosed disease in individuals without signs or symptoms. The effect of diet and nutrition on cancer prevention and recurrence (the return of cancer after treatment) is one of the most studied topics in medicine.

Related Oncology Conferences | Cancer Conferences | Oncologists Conferences

14th World Cancer Therapy Congress, December 05-07, 2016 Philadelphia, Pennsylvania, USA;  Radiation Oncology Conference, November 21-22, 2016 Dubai, UAE; Surgical Oncology Conference, October 03-05, 2016 Atlanta, Georgia, USA;  Leukemia Conference, October 17-18, 2016, Rome, Italy; Nuclear Medicine and  Radiation Therapy Conference,  July 14-15, 2016 Cologne, Germany; Bone Marrow Transplantation Conference, October 17-18, 2016,Italy,  2nd International Cancer Study & Therapy Conference,  Feb 20-22, 2017 Baltimore, USA;  The annual ESMO congress, Copenhagen, Denmark - 07 Oct - 11 Oct 2016;  Molecular Analysis for Personalised Therapy Conference,  London, United Kingdom - 23 Sep - 24 Sep 2016; Multidisciplinary Management of Lung Cancer, June 26-28, 2016, Russia; Multidisciplinary Management of Head and Neck Oncology, June 26-29, 2016, Italy, Fifth JCA-AACR Special Joint Conference on the Latest Advances in Hematological Cancer Research: From Basic Science to Therapeutics, July 13-15, 2016, Urayasu, Worldwide Cancer Events November 21-23, 2016 Dubai, UAE, Breast Cancer Conferences October 03-05, 2016 London, UK, Women’s Health Conferences October 03-05, 2016 London, UK

Cancer Prognosis

Cancer survival rates or survival statistics tell you the percentage of people who survive a certain type of cancer for a specific amount of time. These stats often use an overall five-year survival rate are supported on research from information gathered on hundreds or thousands of individuals with a particular cancer. An overall existing rate includes individuals of all ages and health conditions who have been diagnosed together with your cancer, together with those diagnosed extremely early and people diagnosed terribly late.

Related Oncology Conferences | Cancer Conferences | Oncologists Conferences

12th World Cancer Conference, September 26-28, 2016 London, UK;  Surgical Oncology Conference, October 03-05, 2016 Atlanta, Georgia, USA Leukemia and Bone Marrow Transplantation Conference, October 17-18, 2016, Italy; 13th Asia-Pacific Oncologists Annual Meeting, October 17-19, 2016, Malaysia; 14th World Cancer Convention, November 21-23, 2016 Dubai, UAE; 18th International Psycho Oncology Society Congress, October 17-21, 2016, Ireland; ESMO World Congress on Gastrointestinal Cancer 2016, June 29-July 2, 2016, Spain; ESMO Symposium on Immuno-Oncology 2016, November 4-6, 2016, Switzerland; ESMO Asia 2016 Congress, December 16-19, 2016, Singapore;  European Lung Cancer Conference, May 5-8, 2017, Switzerland; ESMO 2017 Congress, September 8-12, 2017, Spain; World Cancer Congress, October 31-November  3, 2016, France; NCRI Cancer Conference, November  6-9, 2016, London, UK,12th Oncology Conferences Europe September 26-28, 2016 London, UK, 12th Cancer Science Events Europe September 26-28, 2016 London, UK, Cancer Global Conferences Middle East November 21-23, 2016 Dubai, UAE, Oncology Conferences November 21-23, 2016 Dubai, UAE, Worldwide Cancer Events November 21-23, 2016 Dubai, UAE, Breast Cancer Conferences October 03-05, 2016 London, UK, Women’s Health Conferences October 03-05, 2016 London, UK

Cancer and Alternative Medicine

AYUSH system is the most common term used for the cancer treatment. Ayurvedic medicine is an ancient Indian system of medicine which began about 5,000 years ago. It is not just one treatment. It is a way of diagnosing illness and using a wide range of treatments and techniques. Herbal medicine uses plants, or mixtures of plant extracts, to treat illness and promote health. It aims to restore your body's ability to protect, regulate and heal itself. It is a whole body approach, so looks at your physical, mental and emotional wellbeing. It is sometimes called phytomedicine, phytotherapy or botanical medicine. Naturopathic doctors (NDs) believe that cancer arises from an imbalance that causes a systemic breakdown within the body. Homeopathy is based on the theory of treating like with like. So to treat an illness a homeopathic therapist (homeopath) uses tiny doses of a substance that in large doses would actually cause the symptoms of the illness.

Related Oncology Conferences | Cancer Conferences | Oncologists Conferences

Cancer Diagnostics Conference  June 13-15, 2016 Rome, Italy, 2nd Prostate Cancer Conference, August 22-23, 2016 Philadelphia, Pennsylvania, USA, 12th World Cancer Conference, September 26-28, 2016 London, UK, 13th Asia-Pacific Oncologists Annual Meeting, October 17-19, 2016 Kuala Lumpur, Malaysia, 16th Global Annual Oncologists Meeting, April 19-21, 2017 Zurich, Switzerland, ESMO Academy 2016, 26 Aug - 28 Aug 2016, Oxford, United Kingdom, ESMO Symposium on Immuno-Oncology 2016, 04 Nov - 06 Nov 2016,  Lausanne, Switzerland, 8th European Multidisciplinary Meeting on Urological Cancers, 24 Nov - 27 Nov 2016, Milan, Italy, ESMO Asia 2016 Congress, 16 Dec - 19 Dec 2016, Singapore, 48th Annual Congress of the International Society of Paediatric Oncology, 19 Oct - 22 Oct 2016, Dublin, Ireland, World Cancer Congress 2016, 31 Oct - 03 Nov 2016, Paris, France, The Annual Meeting: Future of Patient-Centered Care and Research, June 3-7, 2016, McCormick Place, Chicago, 2016 Annual Scientific Meeting,(COSA 2016) 15 - 17 November 2016, Queensland, Australia, 12th Oncology Conferences Europe September 26-28, 2016 London, UK, 12th Cancer Science Events Europe September 26-28, 2016 London, UK, Cancer Global Conferences Middle East November 21-23, 2016 Dubai, UAE, Oncology Conferences November 21-23, Molecular Biology in Clinical Oncology Workshop, July 24-31, 2016, Colorado, USA,  Fifth JCA-AACR Special Joint Conference on the Latest Advances in Hematological Cancer Research: From Basic Science to Therapeutics, July 13-15, 2016, Urayasu, Japan, ECCO-AACR-EORTC-ESMO Workshop on Methods in Clinical Cancer Research, June 18-24, 2016, Zeist, The Netherlands,2016 Dubai, UAE, Worldwide Cancer Events November 21-23, 2016 Dubai, UAE, Breast Cancer Conferences October 03-05, 2016 London, UK, Women’s Health Conferences October 03-05, 2016 London, UK

Economic Impact on Cancer

Distribution in economics refers to the way total output, income, or wealth is distributed among individuals or among the factors of production (such as labour, land, and capital). In general theory and the national income and product accounts, each unit of output corresponds to a unit of income. Cancer can be a major cause of lack of money. This may be due either to the costs of treating and managing the illness as well as its impact upon people's ability to work. This particularly affects countries that lack comprehensive social health insurance systems and other types of social safety nets. The study is a longitudinal short study of 10,000 hospital patients with a first time diagnosis of cancer. Patients were assigned a socioeconomic status according to the district of residence at diagnosis. Continuity of patients due to cancer living in the most deprived district was compared to survival of patients living in all other districts by model-based period analysis. These major regional socioeconomic inequalities indicate a potential for improving cancer care and survival in Germany. Studies on individual patient data with access to cancer treatment information should be conducted to examine the reasons for these socioeconomic inequalities in cancer survival in more detail.

Related Oncology Conferences | Cancer Conferences | Oncologists Conferences

Gynecologic Oncology Conference, May 19-21, 2016 San Antonio, Texas, USA; 7th Molecular & Cancer Biomarkers Conference, September 15-16, 2016 Berlin, Germany; 12th World Cancer Conference, September 26-28, 2016 London, UK; 8th  Biomarkers & Clinical Research Conference, December 05-07, 2016 Philadelphia, USA; 12th World Cancer Conference, September 26-28, 2016 London, UK, 13th Asia-Pacific Oncologists Annual Meeting, October 17-19, 2016 Kuala Lumpur, Malaysia, 16th Global Annual Oncologists Meeting, April 19-21, 2017 Zurich, Switzerland, ESMO Academy 2016, 26 Aug - 28 Aug 2016, Oxford, United Kingdom, ESMO Symposium on Immuno-Oncology 2016, 04 Nov - 06 Nov 2016,  Lausanne, Switzerland, 8th European Multidisciplinary Meeting on Urological Cancers, 24 Nov - 27 Nov 2016, Milan, Italy, ESMO Asia 2016 Congress, 16 Dec - 19 Dec 2016, Singapore, 48th Annual Congress of the International Society of Paediatric Oncology, 19 Oct - 22 Oct 2016, Dublin, Ireland, World Cancer Congress 2016, 31 Oct - 03 Nov 2016, Paris, France, The Annual Meeting: Future of Patient-Centered Care and Research, June 3-7, 2016, McCormick Place, Chicago, 2016 Annual Scientific Meeting,(COSA 2016) 15 - 17 November 2016, Queensland, Australia. 

Oncology Case reports

Globally it is expected that there are 7.6 million new cancer cases per annum, out of which 52% happen in developing countries. Cancer case reports should include relevant positive and negative findings from history, examination and investigation, and can include clinical photographs; provided these are accompanied by written consent to publish from the patient(s).Case reports should include an up-to-date review of all previous cases in the field.

Related Oncology Conferences | Cancer Conferences | Oncologists Conferences

12th World Cancer Conference, September 26-28, 2016 London, UK;  Surgical Oncology Conference, October 03-05, 2016 Atlanta, Georgia, USA, Leukemia Conference, October 17-18, 2016, Italy; 13th Asia-Pacific Oncologists Annual Meeting, October 17-19, 2016, Malaysia; Bone Marrow Transplantation Conference, October 17-18, 2016,Italy, 14th World Cancer Convention, November 21-23, 2016 Dubai, UAE; 18th International Psycho Oncology Society Congress, October 17-21, 2016, Ireland; ESMO World Congress on Gastrointestinal Cancer 2016, June 29-July 2, 2016, Spain; ESMO Symposium on Immuno-Oncology 2016, November 4-6, 2016, Switzerland; ESMO Asia 2016 Congress, December 16-19, 2016, Singapore;  European Lung Cancer Conference, May 5-8, 2017, Switzerland; ESMO 2017 Congress, September 8-12, 2017, Spain; World Cancer Congress, October 31-November  3, 2016, France; NCRI Cancer Conference, November  6-9, 2016, London, UK,12th Oncology Conferences Europe September 26-28, 2016 London, UK, 12th Oncology Conferences Europe September 26-28, 2016 London, UK, 12th Cancer Science Events Europe September 26-28, 2016 London, UK, Cancer Global Conferences Middle East November 21-23, 2016 Dubai, UAE, Oncology Conferences November 21-23, 2016 Dubai, UAE, Worldwide Cancer Events November 21-23, 2016 Dubai, UAE, Breast Cancer Conferences October 03-05, 2016 London, UK, Women’s Health Conferences October 03-05, 2016 London, UK, Fifth JCA-AACR Special Joint Conference on the Latest Advances in Hematological Cancer Research: From Basic Science to Therapeutics, July 13-15, 2016, Urayasu. 

 

 

 

OMICS International invites all the participants across the globe to attend the "10th Global Oncologists Annual Meeting” slated on July11-13, 2016 at Cologne, Germany.

Theme: To Say There is Life after Cancer

Oncologists 2016 directs towards addressing main issues as well as future strategies of Cancer.This is going to be the largest and most promising international conference where the program includes Clinical Oncologists, Registered Nurses, Nurse practitioners and the entire medical team involved in patient care, researchers, professional, early career individuals and patient advocates who wish to learn principles of tumour immunology and immunotherapy well as decision makers will come to discuss and debate on various aspects of the challenges, risks and investment opportunities throughout the complete information of Cancers. Oncologists Meeting at Cologne, Germany will deal with Prevention, Diagnosis, and Treatment diseases of the Organ-related Cancers and its innovative techniques. Oncologists 2016 will also provide the three days of discussions on methods and strategies related to management and quality improvement of Cancer and as well as to explore the new ideas and concepts on global scale and the topics include lung cancer, breast cancer, bone cancer, leukemia, blood cancer, cervical cancer, colon-rectum cancer, pediatric cancer, surgical cancer, Prostate cancer, thyroid cancer.

·         In Germany on an average of 7% of the people caused to death with Cancer every year

·         Lung Cancer, Blood Cancer, Breast Cancer are most common Cancers in Germany

According to 2012 statistics approximately 14.1 million cases are reported and 8.2 million deaths are reported. Lung, Liver, Stomach and bowel cancers cause the most common deaths among the worldwide that accounts nearly half of all the cancer deaths. About 70% increasein the cases are to be expected over the next 2 decades. In males 5 most common sites of cancer are diagnosed in 2012 were lung, prostate, colorectal and liver cancers. In females 5 most common sites diagnosed were breast, colorectal, cervix, lung and stomach cancer. Nearly 60% of the world’s total new cases occur in the Africa, Asia and Central and South America regions. All over the world Denmark ranks 1st in the cancer deaths USA is accompanied next to it. 

OMICS International along with its subsidiary Conference Series LLC  which is comprised of 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+Workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field is organizing conferences all over the globe. OMICS International hosts numerous Cancer Conferences,Cancer meeting, global cancer conference, European Oncology Conferences, Surgical oncology like skin cancer conference, breast cancer conference, liver cancer conference, lung cancer meetings, and Oncology Conferences where knowledge transfer takes place through debates, round table discussions, poster presentations, workshops, symposia and exhibitions and which helps get possibilities for treating the diseases with new era, technology and research.

Why to attend?

With members from around the world focused on learning about Oncologists; this is your best opportunity to reach the largest assemblage of participants from the Oncologists community, oncology society, European oncology conferences, American oncology society. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Oncology are hallmarks of this conference.

Target Audience

  • Oncologists

  • Radiologists

  • Pathologists

  • Hematologists

  • Academicians

  • Research Scholars

  • Students

  • Hematology Associations & Societies

  • Business Entrepreneurs

  • Software Developing Companies

  • Medical Devices Companies

  • Biomedical Companies

  • Biotechnology Companies

  • Data Management Companies

 

ThemeTo Say There is Life after Cancer

Oncology is the term used for the study of the cancer and it is branch of medicine. Doctor who specializes in the Oncology is known as Oncologist. The vital role of the oncologist is to diagnose the people who are suffering from the cancer and explain the adverse effects during the treatment. There are different types of Oncologists in treating the cancer. Medical Oncologist treats the cancer with the chemotherapy process. Surgical Oncologist involves in the removal of the tumour and the surrounded tissue during the surgery. Radiation Oncologist used to treat the cancer with the Radiation therapy.

Cancer is a common term for a large group of diseases that can affect any organ of the body. Other terms used are malignant tumours and neoplasms. One of the significant features of cancer is the rapid creation of abnormal cells that grow beyond their usual margins, and which can then attack the adjoining parts of the body and spread to other organs. This process is referred to as metastasis. They are the major cause of death from cancer. Tobacco use, alcohol use, unhealthy diet and physical inactivity are the main cancer risk factors worldwide. Chronic infections from hepatitis B (HBV), hepatitis C virus (HCV) and some types of Kaposi’s sarcoma are leading risk factors for cancer in low- and middle-income countries.

Scope and Importance

Cancer is the second leading cause of death worldwide and in all regions of the world. It has undergone a period of dramatic economic, social, and demographic change, resulting in increased life expectancy and prosperity.

Cancer is the leading cause of death in the Germany. The incidence of all cancers is projected to 20% increase by 2010-2030, primarily due to ageing and also possibly due to increased exposure to risk factors for cancer. Breast cancer is the most common cancer among German females (and the most prevalent cancer in both sexes combined), lung cancer, prostate cancer and bowel caners are the most common cancers amongst German males but is extremely rare in females, which reflects the prevalence of smoking (23.0% vs. 0.5%, respectively).

According to 2012 statistics approximately 14.1 million cases are reported and 8.2 million deaths are reported. Lung, Liver, Stomach and bowel cancers cause the most common deaths among the worldwide that accounts nearly half of all the cancer deaths. About 70% increasein the cases are to be expected over the next 2 decades. In males 5 most common sites of cancer are diagnosed in 2012 were lung, prostate, colorectal and liver cancers. In females 5 most common sites diagnosed were breast, colorectal, cervix, lung and stomach cancer. Nearly 60% of the world’s total new cases occur in the Africa, Asia and Central and South America regions. All over the world Denmark ranks 1st in the cancer deaths USA is accompanied next to it.

Breast cancer, the most common tumor in women, presents a high survival percentage: 83% of patients have survived this type of cancer after five years.

Cervical cancer is the third most commonly diagnosed cancer and the fourth leading cause of cancer death in females’ worldwide, accounting for 9% (529,800) of the total new cancer cases and 8% (275,100) of the total cancer deaths among females. More than 85% of these cases and deaths occur in developing countries.

Lung cancer is one of the most aggressive tumors and survival after five years is   very low: only 10% of patients diagnosed with a malignant neoplasm survive for more than five years.

Colorectal cancer (of the colon and rectum), the most common malignant tumors if we group men and women together, presents an average survival rate of 50-55% five years after diagnosis, meaning that half the patients survive this form of cancer.Prostate cancer, today the most common tumors in men, has an increasingly favorable prognosis, with a global survival rate of 76%, which is higher in young adults.

Ovarian cancer presents a very varied prognosis depending on age: whilst 70% of the group between 15 and 44 years survives this form of cancer, this is the case for only 19% of those over 74 years-old.

Oncology Conferences are intended to provide a medium for the communication of results and ideas in the field of cancer science and Treatment regarding to cancers. The conference welcomes contributions in both the basic and clinical aspects of the cancer science and special sections on the Health Care and a forum for Innovative topics related to the cancer science.

Why in Germany?

The population of the Germany is to be 82.56 million for 2015. In Germany as per 2012 out of 100,000 people 283 people are sited with the cancer. Lung and prostate cancers are the most causative cancers in the Germany. On an average of 7% of the people are died due to the cancer every year. Regional differences in the incidence of malignant melanoma of the skin can be observed in Europe and Germany. In recent years the diagnosis of cancer has largely converged in both western and eastern federal states. 

In few years there will be new cases of the Lung cancers in the women age of below forty as well as the men of the same age.

Due to the Demographical development in the Germany, it is expected that there will be more than 20% increase in the new cases of the cancer by the 2030.

Germany maintains the innovative automotive industry and it is the third largest exporter of the goods and it is also the home for the international migrants worldwide.

Conference Highlights

  • Cancer Cell Biology and Diagnostics

  • Organ-related Cancers

  • Cancer Epidemiology

  • Cancer Pharmacology

  • Cancer Vaccines

  • Cancer Prognosis

  •  

  • Treatment for Cancer

  • Ayurvedic Treatment for Cancer

  • Cancer Carcinogenesis and Mutagenesis

  • Cancer Biomarkers

  • Cancer Prevention

  • Oncology Surgical Methods

  • Oncology Practice

  • Economic Impact on Cancer

Why to Attend?

Cancer Conferences orgainzed by OMICS International provides information recent advances in Cancer  reserach, diagnosis, therapy and preventive methedologies.This is your single best opportunity to reach the largest assemblage of participants .World-renowned speakers, the most recent techniques, and the newest updates in cancer research fields are hallmarks of this conference.

Major Cancer Associations across the Globe

  • Irish Cancer Society

  • Cancer Research UK

  • Peter MacCallum Cancer Centre

  • Cancer Society of New Zealand

  • American Society of Clinical Oncology (ASCO)

  • International Agency for Research on Cancer (IARC)

  • American Association for Cancer Research (AACR)

  • International Cancer Research Partnership (ICRP)

  • National Cancer Institute (NIC)

  • The European Cancer Organization (ECCO)

  • Medical Centre Cologne

  • German Cancer Research Centre

Major Cancer Associations in Cologne and Germany 

  • Medical Center Cologne

  • DKFZ Cancer Service

  • Comprehensive Cancer Centre

  • National Center for Tumor Diseases (NCT)

  • German Cancer Aid

  • German Cancer Society

  • German Society of Radiation Oncology

  • German Childhood Cancer Registry

  • Society for Pediatric Oncology and Hematology

  • Cancer Society of Rhineland-Palatinate

  • Cancer Registry Bavaria

  • Krebsregister Baden-Württemberg

  • German Association of Gynecological Oncology

  • German Society of Oncology Pharmacy

  • Children's Eye Cancer Foundation

  • Tumor Registry of Munich

  • North - East German Society of Gynecologic Oncology 

There are 345 Cancer Associations across the world and In Germany there are 21 Cancer Associations and in the Cologne there are 5 Associations. 

Statistical Analysis of Associations for Cancer

Target Audience
 
  • Oncologists

  • Radiologists

  • Pathologists

  • Hematologists

  • Academicians

  • Research Scholars

  • Students

  • Hematology Associations & Societies

  • Business Entrepreneurs

  • Software Developing Companies

  • Medical Devices Companies

  • Biomedical Companies

  • Biotechnology Companies

  • Data Management Companies

Top Universities related to cancer in Germany

  • Heidelberg University

  • University of Cologne

  • University of Berlin

  • Ludwig Maximilian University

  • University of Munich

  • University of Dusseldorf

  • University of Essen

  • University of Gottingen

  • Leipzig University

  • University of Hamburg

 The Universities associated with the Cancer in the Germany are 12 and in Cologne 2 around the world 844.

 

Statistical Analysis of Universities 

Pharmaceutical Companies in Global Cancer Market

There are many Pharmaceutical Companies manufacture the Cancer Drugs. The major Companies are Roche, Novartis, Celgene, Johnson & Johnson, Bristol-Myers Squibb, Lilly, Takeda, AstraZeneca, Pfizer, Merck & Co, Bayer, and UCB.

Companies Manufacture the Cancer Drugs

Hospitals for Cancer treatment

The Hospitals associated with the Cancer Treatment in Germany are nearly 417 and in Cologne are 15 and in the World are around 7200.

  • St John Hopkins Colon Center

  • Cancer Center Cologne

  • MD Anderson Cancer Center

  • Medical Center Cologne

  • Charite in Berlin

  • St George Hospital

  • German Cancer Research Center

  • University Hospital of Heidelberg

  • University Hospital Dresden

  • Mainz University Medical Hospital

  • University Medical Center Hamburg-Eppendorf

  • Munich University Hospital

  • University of Muenster Hospital

Hospitals associated with Cancer

Members Associated in Cancer research

The Members Associated with the Cancer research in the Germany is nearly 12,000 people whereas in Cologne are 2500 people and in the world are around 46500 people.

Members Associated in cancer Research

Market Value for the Cancer

The Market value for the Cancer research in the Germany in 2012 is 6.5$ billion and for 2016will be raise to 10.2$ billion and in the Cologne for 2012 is 1.1$ billion and for 2016 raises to 3.9$ billion and Market value for all over the world in 2012 is 54$ billion and for 2016 it will be raises to 81$ billion

In 2010, the global cancer market was valued at $54 billion, with forecasted Compound Annual Growth Rate (CAGR) growth to $81 billion by 2016. The seven major cancer markets (US, France, Germany, Italy, Spain, United Kingdom and Japan) represented ~79% of the 2010 global cancer market ($43 billion). The US dominated 2010 sales with a market share of 38.5% and the leading ten companies of the global cancer market represented 87.1% ($47 billion) of the total market.

Market Value for Cancer Research in billion $

Amount Funded by the Organisations for All types of Cancers

The numbers of Grants are 1428 for the 15 types of the cancers the funded amount is

707,390,926$

Amount Funded for all Cancers 

Sale Value for the Cancer Drugs

The Sale value for Cancer Drugs that are manufactured by the different Companies Rituximab7.78$ billion manufactured by Roche, Bevacizumab 6.75$ billion manufactured by Roche and Avastin, Trastuzumab 6.56$ billion, Imatinib 4.69$ billion manufactured by Novartis, Pegfilgrastim 4.39$ billion, Lenalidomide 4.28$ billion, Pemetrexed 2.7$ billion, Bortezomib 2.61$ billion, Cetuximab 1.87$ billion, Abiraterone 1.8$ billion.

Cancer Drug and its Sales Value for Different Types of Cancers

Oncologists in Germany

The Number of the Oncologists in the Germany in 2008 is 1717 and it is raised to 2899 by 2015 and by the 2020 the count will be approximately 3806.

Oncologists in Germany 

Incidence rate for the All Types of Cancers all over the World

The New incidence for all types of Cancer reported all over the world in the 2012 is 14,067,894 and it is gradually increased in 2015 is about 15,206,036 the Demographic change noticed is 1,138,142.

All New cases for all Types of Cancers all over the World

Mortality rate for the All Types of Cancers all over the World

The Death rateall types of Cancers reported all over the worldin the 2012 is 8,201,575 and it is gradually increased in 2015 is about 8,885,195 theDemographic change noticed is 683,620.

Death rate for the all Types of Cancers all over the World

Incidence rate for the All Types of Cancers in Germany

The New incidence for all types of Cancer reportedin Germany in the 2012 is 493,780 and it is gradually increased in 2015 is about 518,653 the Demographic change noticed is 24,873.

New cases for all types of Cancers in Germany 

Mortality rate for the All Types of Cancers In Germany

The Death rateall types of Cancer reported in Germany in the 2012 is 217,636 and it is gradually increased in 2015 is about 232,929 theDemographic change noticed is 15,293.

Death rate for all Types of Cancers in Germany 

 

Cancer Summit 2015

OMICS Group’s 5th Asia-Pacific Summit on Cancer Therapy at Park Regis Brisbane, Australia during July 20-22, 2015 was organized with a focus on "Forum for a world without cancer was a great success where eminent keynote speakers from various reputed institutions made their resplendent presence and addressed the gathering.

Cancer Summit-2015 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various newfangled topics related to the field of cancer.

Cancer Summit-2015 Organizing Committee would like to thank the Moderator of the conference, Dr. Rupinder Kaur Kanwar, Deakin University, K who contributed a lot for the smooth functioning of this event.

OMICS Group International would like to convey a warm gratitude to all the Honorable guests and Keynote Speakers of Cancer Summit-2015:

Jagat R Kanwar, Deakin University, Australia

Kwok-nam Leung, The Chinese University of Hong Kong, Hong Kong

Izhak Haviv, Bar Ilan University, Israel

Pascal H G Dujif, University of Queensland, Australia

Veronica J James, Australian National University, Australia

OMICS Group, on behalf of the conference, congratulates the Best Poster awardees for their outstanding performance and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors. We would like to thank the Poster Competition Judge Dr. Izhak Haviv,Bar Ilan University, Israel for his valuable time.

Best Poster Winners:

OMICS Group also took the privilege of felicitating Cancer Summit-2015 Organizing Committee, Editorial Board Members of Journals of Cancer Science & TherapyJournal of Carcinogenesis & Mutagenesis and Journal of Integrative Oncology, Keynote Speakers, Chair and Co-Chairs and Moderator whose support made conference a great success.

With the enormous feedback from the participants and supporters of Cancer Summit-2015, OMICS Group Conferences is glad to announce


Past Reports  Proceedings  Gallery  

Cancer Science-2014

OMICS International hosted 4th World Congress on Cancer Therapy during October 20-22, 2014 at Park Regis Chicago, USA with the theme “Enhanced diagnosis, treatment and management of different cancers". The conference had multiple sessions, Keynote presentations, panel discussions and Poster sessions. We received active participation from various scientists, researchers, students and leaders from the field of oncology who made this event successful.

The conference was initiated with a series of lectures delivered by both Honourable Guests and members of the Keynote forum. The list includes:

Jeffrey B Ulmer, University of Regina, Canada.

Dr. Sudhakar Akul Yakkanti, Stanford Research Institute (SRI) International, Menlo Park California.

Reza Hakkak Professor of Pediatrics in the College of Medicine, Texas, USA

OMICS International thank all our expert presenters from all around the world which includes various outside experts, University representatives and other eminent researchers who supported the conference by facilitating the discussion forums.

Best poster winners:

OMICS Group also took the privilege of felicitating Cancer Science-2014 Organizing Committee, Editorial Board Members of Journals of Cancer Science & TherapyJournal of Carcinogenesis & Mutagenesis and Journal of Integrative Oncology, Keynote Speakers, Chair and Co-Chairs and Moderator whose support made conference a great success.

With the enormous feedback from the participants and supporters of Cancer Science-2014, OMICS Group Conferences is glad to announce.

 


Past Reports  Gallery  

Cancer Science-2013

The 3rd World Congress on Cancer Science & Therapy was organized by OMICS International during October 21-23, 2013 at Double Tree by Hilton Hotel San Francisco Airport, USA. The conference was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 25 countries, who have driven this event into the path of success.

The conference had multiple sessions, Keynote presentations, panel discussions and Poster sessions. Dr. Jimmy T. Efird, Brody School of Medicine, USA Was honourable Moderator for the conference.

The conference proceedings were carried out through various Keynote-presentations by:

Dr. Stewart Sell, Wadsworth Center, USA

Dr. Michael Retsky, Harvard School of Public Health, USA

Dr. Jimmy T. Efird, Brody School of Medicine, USA and the wonderful workshop session was organized by Dr. Dorothee Herlyn, The Wistar Institute, and USA.

OMICS International thank all our expert presenters from all around the world which includes various outside experts, University representatives and other eminent researchers who supported the conference by facilitating the discussion forums.

Best poster winners:

OMICS Group also took the privilege of felicitating Cancer Science-2014 Organizing Committee, Editorial Board Members of Journals of Cancer Science & TherapyJournal of Carcinogenesis & Mutagenesis and Journal of Integrative Oncology, Keynote Speakers, Chair and Co-Chairs and Moderator whose support made conference a great success.

With the enormous feedback from the participants and supporters of Cancer Science-2014, OMICS Group Conferences is glad to announce.

 


Past Reports  Gallery  

Cancer Science-2012

OMICS International 2nd World Congress on Cancer Science & Therapy was held during September 10-12, 2012 at Hilton San Antonio Airport, San Antonio, USA.

The conference proceedings were carried out through effectual keynote lectures by:

Dr. Sudhakar Akul Yakkanti, Boys Town National Research Hospital, USA,

Dr. Alexei G. Basnakian, University of Arkansas for Medical Sciences, USA,

Dr. Dan Dixon, University of South Carolina, USA,

Dr. Sophia Ran, Southern Illinois University School of Medicine, USA

Dr. Homer S Black, Baylor College of Medicine, USA.

OMICS International thank all our expert presenters from all around the world which includes various outside experts, University representatives and other eminent researchers who supported the conference by facilitating the discussion forums.

Best poster winners:

OMICS Group also took the privilege of felicitating Cancer Science-2012 Organizing Committee, Editorial Board Members of Journals of Cancer Science & TherapyJournal of Carcinogenesis & Mutagenesis and Journal of Integrative Oncology, Keynote Speakers, Chair and Co-Chairs and Moderator whose support made conference a great success.

We sincerely thank the Organizing Committee Members for their gracious presence, support, and assistance towards the success of Cancer Science-2012 with the unique feedback from the conference.


 


Past Reports  Gallery  

Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date July 11-13, 2016
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Day 1 Day 2 Day 3
Poster Opportunity Available

Media Partners

Conferenceseries Destinations


Mail us at

Drop us an email for Program enquiry.
oncologists@conferenceseries.net
Sponsors / Exhibiting / Advertising.
oncologists@insightconferences.com
General Queries.
oncologists@conferenceseries.com

View Proceedings of Previous Conferences

Asia Pacific cancer Cancer Therapy 2015
World Cancer Therapy 2015
Euro Cancer Summit 2015
Indo Cancer Summit 2015
Authorization Policy

By registering for the conference you grant permission to Conferenceseries LLC to photograph, film or record and use your name, likeness, image, voice and comments and to publish, reproduce, exhibit, distribute, broadcast, edit and/or digitize the resulting images and materials in publications, advertising materials, or in any other form worldwide without compensation. Taking of photographs and/or videotaping during any session is prohibited. Contact us for any queries.